Pioglitazone raises macular edema risk in diabetes

10/2/2013 | Medscape (free registration)

Type 2 diabetes patients on pioglitazone treatment had a fivefold increased risk of developing macular edema compared with nonusers, a Japanese study found. The risk of macular edema was more than 11 times higher in patients on both insulin and pioglitazone therapy compared with those on neither medication, research showed. The results were presented at the European Association for the Study of Diabetes meeting.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA